马蹄金素杂环衍生物的合成及抗乙肝病毒活性

以马蹄金素[N-(N-苯甲酰基-L-苯丙氨酰基)-O-乙酰基-L-苯丙氨醇,MTS]为先导化合物,设计并合成了16个杂环取代的马蹄金素衍生物,其结构经NMR,ESI-MS和元素分析确证.以HepG2 2.2.15细胞为乙肝病毒(HBV)载体,对合成的马蹄金素衍生物进行了抗HBV活性测试.实验结果表明,在测试浓度范围内,化合物5b(IC50=8.20μg/L,SI=10.26),5g(IC50=5.58μg/L,SI=22.78)和5i(IC50=5.07μg/L,SI=16.67)的抗HBV活性较强;在8μg/mL的浓度下,其抑制率分别为56.57%,67.06%和66.83%.     

硝基修饰MOF-5材料的制备及催化氨基甲酸酯热分解!

采用直接混合法在室温下制备了含硝基的金属-有机骨架材料MOF-5-NO2,并采用X射线衍射分析,红外光谱,N2等温吸附和扫描电子显微镜对其进行了表征.结果表明,MOF-5-NO2具有与MOF-5相似的晶体结构和表面形貌,二者都具有高比表面积及微孔特性,但由于硝基的吸电子效应,MOF-5-NO2比MOF-5具有更强的Lewis酸性,因而对氨基甲酸酯热分解制备异氰酸酯的反应具有良好的催化活性.在无溶剂条件下,MOF-5-NO2使苯氨基甲酸甲酯热分解的反应速度显著提高,催化剂转化频率达到ZnO的7倍以上;二苯甲烷二氨基甲酸苯酯热分解的中间产物减少,二苯甲烷二异氰酸酯的收率达到81.6%.     

煤热解过程中含氮产物的析出及金属离子的催化特性研究

选择3种典型煤种为研究对象,通过脱灰和添加含Fe、Ca、Na等金属盐,研究煤热解过程中金属离子对含氮气相产物析出特性的影响以及与煤种和温度的交互关联。结果表明,脱灰煤HCN和NH3的产率均比原煤样下降,而随温度的升高HCN的产率逐渐增大,NH3的产率则先增加后减小,在800℃有最大值。金属离子对不同变质程度煤的含氮气相产物析出的催化作用不同;Fe和Na抑制中等变质程度煤HCN的析出,而对低变质程度煤起促进作用,Ca则对HCN的析出均有一定的促进作用。而对于NH3的形成,3种离子均对中等变质程度煤有抑制作用,而对低变质程度的煤则有促进作用。不同金属离子对HCN和NH3析出的催化作用均有一定的范围。煤热解时含氮气相产物的析出是煤中固有多种金属离子共同作用的结果。     

增压O_2/CO_2气氛下煤燃烧特性实验研究

增压O2/CO2燃烧是一种可高效分离回收CO2的新兴燃烧技术,其燃烧机理与常压空气、常压O2/CO2燃烧存在较大差异。在加压热重分析仪上研究了增压条件下总压、氧浓度、气氛及粒径等反应参数对美国烟煤和淮北无烟煤燃烧特性的影响,确定了煤的着火温度,并对其进行燃烧动力学分析。结果表明,增压O2/CO2气氛下,随着压力或氧浓度的增加,DTG曲线向低温区移动,煤样整体燃烧速率加快。压力提升、氧浓度增加及煤粉细化均可改善O2/CO2气氛下煤样的着火特性。常压O2/CO2气氛下煤粉燃烧基本属于一级反应;增压O2/CO2气氛下,低温区属于0.5级反应,而高温区属于1.5级反应。     

TG-MS与Py-GC相结合法研究惰性气氛下含硫模型化合物热解过程中硫的脱除及释放行为研究

采用热重-质谱法(TG-MS)和热解-气相色谱法(Py-MS)相结合的方法对模型化合物(十四硫醇、二丁基硫醚、苯硫醚、二甲基噻吩、苯并噻吩和二苯并噻吩等)在惰性气氛下硫的脱除及释放行为进行研究。惰性气氛下硫的脱除顺序为:十四硫醇>二丁基硫醚>二甲基噻吩>苯并噻吩>苯硫醚>二苯并噻吩,苯硫醚除外,该顺序与含硫官能团的热分解顺序一致。在热解过程中,所有模型化合物在质谱和气相色谱仪上均被检测到SO₂;除苯硫醚和二苯并噻吩外,其他模型化合物中均检测到了COS;而只在十四硫醇、二丁基硫醚和二甲基噻吩中检测到了H₂S。且热解气中SO₂含量要显著高于H₂S和COS。这是由于活性炭作载体时,惰性气氛下内部氢的含量显著小于内部氧的含量,所以大多数的含硫自由基易与内部氧结合以SO₂的形式逸出。对于苯硫醚、苯并噻吩和二苯并噻吩中没有检测到H₂S,是由于内部氢的不足,使得含硫自由基不能与内部氢结合,所以没有检测到H₂S逸出。     

油页岩的~(13)C-NMR特征及FLASHCHAIN热解模拟研究

采用固体13C-NMR核磁共振技术表征了甘肃窑街矿区油页岩的碳骨架结构,分析并计算了油母质团簇化学结构参数,包括团簇平均碳原子数、芳碳原子数、脂碳原子数及芳环数。在热重红外分析仪(TG-FTIR)上进行了油页岩的热解实验,得到了热解产物的生成规律。结合样品的团簇化学结构参数,采用基于油页岩结构的FLASHCHAIN模型模拟其热解产物的生成过程;模拟结果与TG-FITR实验数据符合较好,印证了模型预测的合理性。     

铜催化芳硼酸与亚磷酸酯在空气下的有氧碳-磷氧化偶联反应

在Cu(OAc)2/TMEDA体系催化下,芳硼酸与亚磷酸二乙酯可在室温下以空气为直接氧化剂通过氧化偶联反应生成芳基膦酸酯化合物.该反应使用较为廉价低毒的铜盐为催化剂,不怕水、不怕氧,底物适用范围较广,目标产物选择性高、收率良好.因此,与已知金属催化卤代芳烃的碳-磷偶联反应相比是一种相对温和高效的合成芳基膦酸酯的方法.     

发展高效的不对称Suzuki-Miyaura偶联反应及其合成应用

为解决不对称Suzuki-Miyaura交叉偶联反应中活性和选择性问题,我们设计并发展了一系列结构刚性的手性联芳基单膦配体.在发展高活性的大位阻交叉偶联反应方面,成功地实现了邻位四取代芳基芳基之间的Suzuki-Miyaura交叉偶联,并发展了官能团化的大位阻交叉偶联,在邻位二取代芳基溴苯与二级烷基硼酸之间的大位阻芳基烷基交叉偶联中也取得进展.在发展高立体选择性的交叉偶联反应方面,我们采用手性大位阻单膦配体和底物间次级作用相结合的设计理念,利用苯并噁唑啉酮辅基和芳基间的π-π作用,成功地发展了高立体选择性的邻位酰基化芳基芳基间不对称Suzuki-Miyaura偶联;利用极性基团双(2-氧代-3-噁唑烷基)次磷酰基(BOP)辅基和芳基间的极性π作用,成功地实现了应用性强的邻位氧基取代芳基芳基间高效不对称Suzuki-Miyaura偶联.最后我们首次将高效的不对称SuzukiMiyaura偶联方法学应用于天然产物合成,完成了手性联芳基天然产物Korupensamine A和Korupensamine B的高效不对称合成,并完成天然产物Michellamine B的立体选择性全合成.     

Ultra‐fast LC–ESI‐MS/MS method for the simultaneous determination of six highly toxic Aconitum alkaloids from Aconiti kusnezoffii radix in rat plasma and its application to a pharmacokinetic study

A fast, sensitive, and efficient ultra‐fast LC–ESI‐MS/MS method was developed for the simultaneous quantitation of six highly toxic Aconitum alkaloids, that is, aconitine, mesaconitine, hypaconitine, benzoylaconine, benzoylmesaconine, and benzoylhypaconine, in rat plasma after oral administration of crude ethanol extracts from Aconiti kusnezoffii radix by ultrasonic extraction, reflux extraction for 1 h, and reflux extraction for 3 h, respectively. The separation of six Aconitum alkaloids and aminopyrine (internal standard) was performed on an InertSustain® C₁₈ column, and the quantification of the analytes was performed on a 4000Q ultra‐fast LC–MS/MS system with turbo ion spray source in the positive ion and multiple‐reaction monitoring mode. Absolute recoveries ranged within 65.06–85.1% for plasma samples. The intra‐ and interday precision and accuracy of analytes were satisfactory. The methods were validated with sensitivity reaching the lower LOQ for aconitine, mesaconitine, hypaconitine, benzoylaconine, benzoylmesaconine, and benzoylhypaconine, which were 0.025, 0.025, 0.050, 0.025, 0.025, and 0.100 ng/mL, respectively. The method was successfully applied to a pharmacokinetic study of six Aconitum alkaloids in rat plasma after oral administration of crude ethanol extracts from the raw root of Aconitum kusnezoffii Reichb. by three different extraction processes.     

Combination of UHPLC/Q-TOF-MS,NMR spectroscopy,and ECD calculation for screening and identification of reactive metabolites of gentiopicroside in humans

The metabolic investigation of natural products is a great challenge because of unpredictable metabolic pathways, little knowledge on metabolic effects, and lack of recommended analytical methodology. Herein, a combined strategy based on ultrahigh-performance liquid chromatography coupled with electrospray ionization quadrupole time-of-flight tandem mass spectrometry (UHPLC/Q-TOF-MS), nuclear magnetic resonance (NMR) spectroscopy, and electronic circular dichroism (ECD) calculation was developed and employed for the human metabolism study of gentiopicroside (GPS), a naturally hepato-protective iridoid glycoside. The whole metabolic study consisted of three major procedures. First, an improved UHPLC/Q-TOF-MS method was used to separate and detect a total of 15 GPS metabolites that were obtained from urine samples (0 to 72 h) of 12 healthy male participants after a single 50-mg oral dose of GPS. Second, a developed “MS-NMR-MS” method was applied to accurately identify molecular structures of the observed metabolites. Finally, given that the associated stereochemistry may be a crucial factor of the metabolic activation, the absolute configuration of the reactive metabolites was revealed through chemical calculations. Based on the combined use, a pair of diastereoisomers (G05 and G06) were experimentally addressed as the bioreactive metabolites of GPS, and the stereochemical determination was completed. Whereas several novel metabolic transformations, occurring via oxidation, N-heterocyclization and glucuronidation after deglycosylation, were also observed. The results indicated that GPS has to undergo in vivo metabolism-based activation to generate reactive molecules capable of processing its hepato-protective activity.